Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2001 2
2004 4
2005 4
2006 1
2007 1
2008 6
2009 7
2010 4
2011 7
2012 9
2013 6
2014 10
2015 5
2016 3
2017 7
2018 11
2019 10
2020 6
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31149947

101 results

Results by year

Filters applied: . Clear all
Page 1
HIV elite control is associated with reduced TRAILshort expression.
Paim AC, Cummins NW, Natesampillai S, Garcia-Rivera E, Kogan N, Neogi U, Sönnerborg A, Sperk M, Bren GD, Deeks S, Polley E, Badley AD. Paim AC, et al. AIDS. 2019 Sep 1;33(11):1757-1763. doi: 10.1097/QAD.0000000000002279. AIDS. 2019. PMID: 31149947 Free PMC article.
TRAILshort Protects against CD4 T Cell Death during Acute HIV Infection.
Natesampillai S, Paim AC, Cummins NW, Chandrasekar AP, Bren GD, Lewin SR, Kiem HP, Badley AD. Natesampillai S, et al. J Immunol. 2019 Aug 1;203(3):718-724. doi: 10.4049/jimmunol.1900271. Epub 2019 Jun 12. J Immunol. 2019. PMID: 31189571 Free PMC article.
The TRAIL: TRAILshort Axis in HIV Immunopathology.
Aboulnasr F, Paranjape G, Badley AD. Aboulnasr F, et al. Crit Rev Immunol. 2018;38(6):491-503. doi: 10.1615/CritRevImmunol.2019029632. Crit Rev Immunol. 2018. PMID: 31002603 Free PMC article. Review.
Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells.
Aboulnasr F, Krogman A, Graham RP, Cummins NW, Misra A, Garcia-Rivera E, Anderson JR, Natesampillai S, Kogan N, Aravamudan M, Nie Z, Chung TDY, Buick R, Feldman AL, King RL, Novak AJ, Ansell SM, Kenderian S, Badley AD. Aboulnasr F, et al. Clin Cancer Res. 2020 Nov 1;26(21):5759-5771. doi: 10.1158/1078-0432.CCR-20-0251. Epub 2020 Jul 15. Clin Cancer Res. 2020. PMID: 32669373 Free PMC article.
Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.
Chehimi J, Papasavvas E, Tomescu C, Gekonge B, Abdulhaqq S, Raymond A, Hancock A, Vinekar K, Carty C, Reynolds G, Pistilli M, Mounzer K, Kostman J, Montaner LJ. Chehimi J, et al. J Virol. 2010 Mar;84(6):2762-73. doi: 10.1128/JVI.01350-09. Epub 2009 Dec 30. J Virol. 2010. PMID: 20042498 Free PMC article.
Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.
Egaña-Gorroño L, Escribà T, Boulanger N, Guardo AC, León A, Bargalló ME, Garcia F, Gatell JM, Plana M, Arnedo M; HIV Controllers Consortium of the AIDS Spanish Network. Egaña-Gorroño L, et al. PLoS One. 2014 Sep 16;9(9):e106360. doi: 10.1371/journal.pone.0106360. eCollection 2014. PLoS One. 2014. PMID: 25225963 Free PMC article.
101 results